The present study sought to evaluate the therapeutic potential of EVs derived from ADSCs and BMMSCs with and without transfection with Smad2/3 siRNA and of Smad2/3 siRNA alone in a hamster model of atherosclerosis-associated cardiac hypertrophy. Here, SMAD2 is linked to cardiac hypertrophy.